Clinical trials
Phase 3 Neurodevelopmental Disorders trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 6 |
| Completed | 2 |
| Enrolling by invitation | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Longboard Pharmaceuticals | 3 |
| Taysha Gene Therapies, Inc. | 2 |
| Arizona State University | 1 |
| Emalex Biosciences Inc. | 1 |
| Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 1 |
| National Institute of Mental Health (NIMH) | 1 |
| Neurogene Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurodevelopmental Disorders | 10 |
| Nervous System Diseases | 4 |
| Epilepsy | 3 |
| Genetic Diseases, X-Linked | 3 |
| Intellectual Disability | 3 |
| Neurologic Manifestations | 3 |
| Pathologic Processes | 3 |
| Rett Syndrome | 3 |
| Seizures | 3 |
| Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.